APA (7th ed.) Citation

Xue, Z., Zhao, K., Sun, Z., Wu, C., Yu, B., Kong, D., & Xu, B. (2021). Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathway. Wiley.

Chicago Style (17th ed.) Citation

Xue, Zhe, Kai Zhao, Zhenghui Sun, Chen Wu, Bowen Yu, Dongsheng Kong, and Bainan Xu. Isorhapontigenin Ameliorates Cerebral Ischemia/reperfusion Injury via Modulating Kinase Cε/Nrf2/HO‐1 Signaling Pathway. Wiley, 2021.

MLA (8th ed.) Citation

Xue, Zhe, et al. Isorhapontigenin Ameliorates Cerebral Ischemia/reperfusion Injury via Modulating Kinase Cε/Nrf2/HO‐1 Signaling Pathway. Wiley, 2021.